IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

被引:3202
作者
Langrish, CL
Chen, Y
Blumenschein, WM
Mattson, J
Basham, B
Sedgwick, JD
McClanahan, T
Kastelein, RA
Cua, DJ
机构
[1] DNAX Res Inst Mol & Cellular Biol Inc, Discovery Res, Palo Alto, CA 94304 USA
[2] DNAX Res Inst Mol & Cellular Biol Inc, Expt Pathol & Pharmacol, Palo Alto, CA 94304 USA
[3] DNAX Res Inst Mol & Cellular Biol Inc, Bioinformat, Palo Alto, CA 94304 USA
关键词
D O I
10.1084/jem.20041257
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin (IL)-23 is a heterodimeric cytokine composed of a unique p19 subunit, and a common p40 subunit shared with IL-12. IL-12 is important for the development of T helper (Th)1 cells that are essential for host defense and tumor suppression. In contrast, IL-23 does not promote the development of interferon-gamma-producing Th1 cells, but is one of the essential factors required for the expansion of a pathogenic CD4(+) T cell population, which is characterized by the production of IL-17, IL-17F, IL-6, and tumor necrosis factor. Gene expression analysis of IL-23-driven autoreactive T cells identified a unique expression pattern of proinflammatory cytokines and other novel factors, distinguishing them from IL-12-driven T cells. Using passive transfer studies, we confirm that these IL-23-dependent CD4(+) T cells are highly pathogenic and essential for the establishment of organ-specific inflammation associated with central nervous system autoimmunity.
引用
收藏
页码:233 / 240
页数:8
相关论文
共 36 条
[1]  
Aarvak T, 1999, J IMMUNOL, V162, P1246
[2]   Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 [J].
Aggarwal, S ;
Ghilardi, N ;
Xie, MH ;
de Sauvage, FJ ;
Gurney, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1910-1914
[3]  
Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1
[4]   RETRACTED: The IL-12Rβ2 gene functions as a tumor suppressor in human B cell malignancies (Retracted Article) [J].
Airoldi, I ;
Di Carlo, E ;
Banelli, B ;
Moserle, L ;
Cocco, C ;
Pezzolo, A ;
Sorrentino, C ;
Rossi, E ;
Romani, M ;
Amadori, A ;
Pistoia, V .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (11) :1651-1659
[5]   Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12 [J].
Becher, B ;
Durell, BG ;
Noelle, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (04) :493-497
[6]   Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain [J].
Cua, DJ ;
Sherlock, J ;
Chen, Y ;
Murphy, CA ;
Joyce, B ;
Seymour, B ;
Lucian, L ;
To, W ;
Kwan, S ;
Churakova, T ;
Zurawski, S ;
Wiekowski, M ;
Lira, SA ;
Gorman, D ;
Kastelein, RA ;
Sedgwick, JD .
NATURE, 2003, 421 (6924) :744-748
[7]   Development of anti-TNF therapy for rheumatoid arthritis [J].
Feldmann, M .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (05) :364-371
[8]  
Ferber IA, 1996, J IMMUNOL, V156, P5
[9]   Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice [J].
Ghilardi, N ;
Kljavin, N ;
Chen, Q ;
Lucas, S ;
Gurney, AL ;
de Sauvage, FJ .
JOURNAL OF IMMUNOLOGY, 2004, 172 (05) :2827-2833
[10]   IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: Evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination [J].
Gran, B ;
Zhang, GX ;
Yu, S ;
Li, JF ;
Chen, XH ;
Ventura, ES ;
Kamoun, M ;
Rostami, A .
JOURNAL OF IMMUNOLOGY, 2002, 169 (12) :7104-7110